Merck & Co., Inc. (MRK)
115.88
+0.45
(+0.39%)
USD |
NYSE |
Mar 17, 16:00
115.65
-0.23
(-0.20%)
After-Hours: 20:00
Merck EPS Diluted (Quarterly) : 1.191 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Biogen, Inc. | -0.3333 |
| Gilead Sciences, Inc. | 1.742 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.962B |
| Revenue (Quarterly) | 16.32B |
| Total Expenses (Quarterly) | 13.36B |
| Enterprise Value | 321.29B |
| Gross Profit Margin (Quarterly) | 70.49% |
| Profit Margin (Quarterly) | 18.15% |
| Earnings Yield | 6.28% |
| Operating Earnings Yield | 9.19% |
| Normalized Earnings Yield | 7.464 |